Two remarkable dyspneic men: when should terminal sedation be administered?
Lanuke
Kathryn
K
University of Alberta, Edmonton, Alberta, Canada.
Fainsinger
Robin L
RL
DeMoissac
Donna
D
Archibald
James
J
D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000503:physiopathology; D000368:Aged; D004417:Dyspnea / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage*; D008175:Lung Neoplasms / Q000503:physiopathology; D008297:Male; D018447:Medical Futility; D008875:Middle Aged; D010166:Palliative Care / Q000941:ethics / Q000592:standards*; D026684:Personal Autonomy; D011658:Pulmonary Fibrosis / Q000503:physiopathology; D013727:Terminal Care / Q000941:ethics / Q000592:standards*
D006993:Hypnotics and Sedatives